Fennec Pharmaceuticals Inc (FENC)
9.21
+0.05
(+0.55%)
USD |
NASDAQ |
Apr 26, 16:00
9.23
+0.02
(+0.22%)
After-Hours: 20:00
Fennec Pharmaceuticals Market Cap: 249.59M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 26, 2024 | 249.59M |
| April 25, 2024 | 248.24M |
| April 24, 2024 | 245.80M |
| April 23, 2024 | 250.40M |
| April 22, 2024 | 254.20M |
| April 19, 2024 | 253.11M |
| April 18, 2024 | 259.35M |
| April 17, 2024 | 262.87M |
| April 16, 2024 | 278.04M |
| April 15, 2024 | 279.94M |
| April 12, 2024 | 284.28M |
| April 11, 2024 | 293.49M |
| April 10, 2024 | 289.16M |
| April 09, 2024 | 295.12M |
| April 08, 2024 | 293.49M |
| April 05, 2024 | 289.70M |
| April 04, 2024 | 295.66M |
| April 03, 2024 | 291.87M |
| April 02, 2024 | 297.83M |
| April 01, 2024 | 293.76M |
| March 28, 2024 | 301.35M |
| March 27, 2024 | 300.40M |
| March 26, 2024 | 295.12M |
| March 25, 2024 | 298.10M |
| March 22, 2024 | 292.04M |
| Date | Value |
|---|---|
| March 21, 2024 | 299.34M |
| March 20, 2024 | 299.34M |
| March 19, 2024 | 297.71M |
| March 18, 2024 | 299.34M |
| March 15, 2024 | 268.78M |
| March 14, 2024 | 270.40M |
| March 13, 2024 | 267.70M |
| March 12, 2024 | 262.83M |
| March 11, 2024 | 256.07M |
| March 08, 2024 | 261.08M |
| March 07, 2024 | 259.73M |
| March 06, 2024 | 264.59M |
| March 05, 2024 | 258.65M |
| March 04, 2024 | 264.05M |
| March 01, 2024 | 265.41M |
| February 29, 2024 | 255.95M |
| February 28, 2024 | 251.62M |
| February 27, 2024 | 252.70M |
| February 26, 2024 | 247.03M |
| February 23, 2024 | 243.24M |
| February 22, 2024 | 244.05M |
| February 21, 2024 | 240.00M |
| February 20, 2024 | 238.38M |
| February 16, 2024 | 243.51M |
| February 15, 2024 | 247.03M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
65.66M
Minimum
Jun 12 2019
310.10M
Maximum
Dec 28 2023
181.71M
Average
187.16M
Median
Sep 26 2022
Market Cap Benchmarks
| Pfizer Inc | 143.43B |
| OptiNose Inc | 95.95M |
| NovaBay Pharmaceuticals Inc | 2.372M |
| Palatin Technologies Inc | 29.37M |
| iBio Inc | 6.132M |
Market Cap Related Metrics
| PS Ratio | 11.55 |
| Price | 9.21 |
| Earnings Yield | -6.61% |